Elevance Health Total Long Term Liabilities 2010-2024 | ELV
Elevance Health total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Elevance Health total long term liabilities for the quarter ending December 31, 2024 were $30.621B, a 7.06% increase year-over-year.
- Elevance Health total long term liabilities for 2023 were $27.732B, a 3.75% increase from 2022.
- Elevance Health total long term liabilities for 2022 were $26.729B, a 1.07% increase from 2021.
- Elevance Health total long term liabilities for 2021 were $26.447B, a 10.37% increase from 2020.
| Elevance Health Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $27,732 |
| 2022 | $26,729 |
| 2021 | $26,447 |
| 2020 | $23,963 |
| 2019 | $22,193 |
| 2018 | $21,065 |
| 2017 | $20,681 |
| 2016 | $18,688 |
| 2015 | $19,581 |
| 2014 | $18,672 |
| 2013 | $18,458 |
| 2012 | $19,158 |
| 2011 | $12,976 |
| 2010 | $12,345 |
| 2009 | $12,588 |
| Elevance Health Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $30,621 |
| 2024-06-30 | $28,878 |
| 2024-03-31 | $26,850 |
| 2023-12-31 | $27,732 |
| 2023-09-30 | $28,602 |
| 2023-06-30 | $29,285 |
| 2023-03-31 | $29,691 |
| 2022-12-31 | $26,729 |
| 2022-09-30 | $25,696 |
| 2022-06-30 | $25,702 |
| 2022-03-31 | $24,722 |
| 2021-12-31 | $26,447 |
| 2021-09-30 | $27,090 |
| 2021-06-30 | $27,257 |
| 2021-03-31 | $27,016 |
| 2020-12-31 | $23,963 |
| 2020-09-30 | $24,092 |
| 2020-06-30 | $24,999 |
| 2020-03-31 | $23,667 |
| 2019-12-31 | $22,193 |
| 2019-09-30 | $23,243 |
| 2019-06-30 | $21,968 |
| 2019-03-31 | $21,843 |
| 2018-12-31 | $21,065 |
| 2018-09-30 | $21,177 |
| 2018-06-30 | $21,137 |
| 2018-03-31 | $21,532 |
| 2017-12-31 | $20,681 |
| 2017-09-30 | $17,949 |
| 2017-06-30 | $19,238 |
| 2017-03-31 | $19,677 |
| 2016-12-31 | $18,688 |
| 2016-09-30 | $18,619 |
| 2016-06-30 | $19,012 |
| 2016-03-31 | $19,501 |
| 2015-12-31 | $19,581 |
| 2015-09-30 | $20,734 |
| 2015-06-30 | $20,528 |
| 2015-03-31 | $19,906 |
| 2014-12-31 | $18,672 |
| 2014-09-30 | $19,369 |
| 2014-06-30 | $18,750 |
| 2014-03-31 | $18,847 |
| 2013-12-31 | $18,458 |
| 2013-09-30 | $19,413 |
| 2013-06-30 | $19,046 |
| 2013-03-31 | $19,061 |
| 2012-12-31 | $19,158 |
| 2012-09-30 | $17,918 |
| 2012-06-30 | $14,713 |
| 2012-03-31 | $13,013 |
| 2011-12-31 | $12,976 |
| 2011-09-30 | $13,046 |
| 2011-06-30 | $12,589 |
| 2011-03-31 | $12,780 |
| 2010-12-31 | $12,345 |
| 2010-09-30 | $12,529 |
| 2010-06-30 | $11,533 |
| 2010-03-31 | $11,851 |
| 2009-12-31 | $12,588 |
| 2009-09-30 | $12,504 |
| 2009-06-30 | $12,749 |
| 2009-03-31 | $12,566 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $90.846B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Revvity (RVTY) | United States | $13.997B | 23.47 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |